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PHYSICAL EXERCISE PERFORMED BY RESIDENTIAL ELDERLY OF 
HIGH AGE, IS SAFE HOWEVER DOES NOT AFFECT HEART FAIL-
URE SYMPTOMS, NT-PROBNP AND CARDIOVASCULAR-
METABOLIC INDICES; A PILOT, SINGLE-BLINDED RCT. 






















Does exercise benefit care-home residents afflicted with cardiovascular-metabolic diseases who 
are leading a sedentary life? Exercise effects were investigated on chronic heart failure (CHF) 
and the metabolic syndrome.  
METHODS. For 16 weeks a twice weekly exercise was performed by the exercise group and a 
non-physical program by the control group. Cardiovascular-metabolic markers were measured 
[(N-terminal-pro B-type-natriuretic peptides(NT-proBNP), waist, HbA1c, diabetes mellitus type 
2 (T2DM), plasma lipids and blood pressure].  
RESULTS. Analysis of aged 85 years showed neither significant changes in exercise groups 
(24) compared to controls (22) nor lasting injury from falls. Only exercise group attendance is 
inversely related  to non-fasting triglycerides (p=0.024). 
CONCLUSION. In care-home residents, guided physical exercise is safe in the short term but 
may be less effective in reducing chronic heart failure symptoms, NT-proBNP concentrations 
and the metabolic syndrome. We have explained the neutral results by the high age (85 year 
on average) accompanied by low muscle endurance, and by a training schedule that might be 




The Dutch guideline for cardiovascular risk management (CVRM) states that the 10-year risk of 
cardiovascular diseases (CVD) of 70+ elderly should exceed 20% and that the elderly should 
be eligible for medication when lifestyle changes fail (1). 
Care home elderly (residents) are even more at cardiovascular (CV) risk when compared to 
70+ elderly because the first group (of elderly) are sedentary most often and they are suffering 
from multimorbidity. Examples of multimorbidity are diabetes mellitus type 2 (T2DM), CV dis-
eases, notably heart failure (CHF),  cerebrovascular ischemic attack (CVA)  (2). 
In the daily practice of geriatric medicine, these risks are addressed pharmacologically rather 
than by a change of life style such as physical activity (1;3;4). Changes of lifestyle require mo-
tivation to adjust behaviour while drug intake barely takes extra effort. This is one of the reasons 
why residential elderly remain sedentary. Their daily physical activity is three to eleven minutes. 
However, this inactivity of residents is inconsistent with the recommendations of the CVRM 
guideline (5-9). This inconsistency is also based on perspectives of a limited lifespan and fear 
of  falling. These anxieties prevent residents from becoming physically active. Chronic heart 
failure (CHF) is defined as a syndrome resulting from myocardial muscle dysfunction with usual 
exposure of characteristic symptoms (10). Natriuretic peptides, notably B-type natriuretic pep-
tide (BNP) and amino-terminal pro-B-type NP (NT-proBNP) are well established CHF bio-
markers. They are widely used for CHF diagnosis, follow-up and prognosis (11), while they also 
provide opportunities for biomarker-guided treatment optimization (12). 
The metabolic syndrome was defined as the presence of at least three out of five of the follow-
ing symptoms (13): central obesity, compromised glucose homeostasis or diagnosed T2DM, 
atherogenic dyslipidemia and hypertension (14;15). Both CV and metabolic derailments have 
atherosclerosis as a central pathophysiological phenomenon that is eligible for lifestyle changes 
as physical exercise.  
In the present study we sought to investigate two aspects of physical exercise with/in residents, 
its safety and changes of CHF symptoms and a marker, and markers of the metabolic syn-
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drome. We aimed to study whether participation in a predefined exercise program is safe and 
whether symptoms and a marker of CHF and markers of the metabolic syndrome, will change 




This pilot study was designed as a multicenter single-blinded randomized controlled trial. The 
end points were CHF symptoms, a marker, and the metabolic syndrome. This study was part of 
the Benefit study (). The Benefit study took place in 14 care homes. The care home residents 
in the present study participated in the same intervention program as those in the Benefit study. 
This program consisted of either physical exercise or a program without exercise. The Benefit 
and present study differed in size (Benefit: 14 care homes, present study: 4 care homes) and 
end points. The Benefit study end points consisted of physical fitness, functional performance, 
activities of daily life and quality of life (16). 
 
Subject selection.  
From March 2010 to December 2011, we invited all elderly of four residential homes in Gronin-
gen to participate in the study. The inclusion criteria were: no dementia, the ability to walk at 
least ten meters, understanding the impact of the study. Potential participants had to sign an 
informed consent. Exclusion criteria were age <70 years, disturbed cognition (Mini-Mental 
State Examination test <20; range 0-30), serious aphasia, heart failure New York Heart Asso-
ciation (NYHA)-class IV, terminal phase, and metastatic cancer. To the best of our knowledge 
there was no literature available about effects of exercise programs on patients with CHF and 
CV-metabolic indices among the elderly with multimorbidities. Since a meaningful estimation of 





Endpoint definitions (Table 1) 
Chronic heart failure was defined as a syndrome resulting from myocardial muscle dysfunction 
with the usual exposure of characteristic symptoms such as shortness of breath (dyspnoea) and 
fatigue, both in rest, during activity and during exertion (in three conditions)(10). Symptoms of 
CHF were estimated as changed if dyspnea (scores 0-3)  and or fatigue (scores 0-3) de-
crease with at least one score point. The metabolic syndrome was defined as the presence of at 
least three out of five of the following symptoms (17): central obesity (waist circumference ≥102 
males or ≥88 females, compromised glucose homeostasis (increased glycated hemoglobin >41 
mmol/mol or the diagnosis T2DM), atherogenic dyslipidemia (high triglycerides >150 mg/dL, 
low HDL-cholesterol <40 mg/dL for males or <50 for females) and increased systolic blood 
pressure (>130 mm Hg) (14;15). Smoking is not included in this enumeration. Participation in 
the exercise program was defined as safe if falls or unfavourable events during exercise ses-
sions occurred in <4% [16 out of 32 followed sessions x 24 (number of) exercising resi-
dents=384 occasions/100%=around 4% accidents]. The chosen changes of endpoint variables 
are represented in Table 1. 
Motives for non-participation. As expected (17), a relatively low participation was taken into 
account. Participants were randomly assigned to the two  groups at each location. Intending to 
analyse motives for not participating, we inquired those who refused participation about their 
reasons. In order to compare characteristics of non-participants to those of participants, biomet-
ric data of the first group (age, weight, height, heart rate and blood pressure) were collected  by 
the investigator. Medical history and medication were obtained from general practitioners. The 
reasons for refusal were grouped into intrinsic motives (‘no realization of benefits of exercise’ 
and ‘does not want to adhere to the program’) and extrinsic motives. The latter were defined as 







During two visits before and after the intervention, all participants were subjected to a structured 
interview, specific physical examination and biometric measurements. Blood samples were 
taken within two hours after breakfast and lunch. Participants were physically examined for car-
diopulmonary symptoms, blood pressure  (Heine gamma-G5®; www.Heine.com), symptoms or 
complaints of the abdomen, joints, back, visual ability and hearing. Multimorbidity was scored 
using the Charlson Comorbidity Index (18;19). Blood samples were taken two hours after 
breakfast or lunch. For logistic reasons, it was not feasible to collect fasting blood samples. The 
Medical Ethical Committee of the UMCG approved of the study (number 2010.178). 
 
Interventions 
The exercise program included moderate to high-intensity training sessions (16). 
In each session, the participants performed progressive resistance training of upper and lower 
extremities and trunk, static and dynamic balance training, and functional training. Elastic bands 
(20) were used for resistance training. The following muscle groups were trained: biceps, tri-
ceps, shoulder, back, abdominal and hip muscles, quadriceps femoris, gastrocnemic, peroneus 
and tibialis as well as foot muscles. The volume of resistance training was gradually increased 
from one set of eight repetitions in the first five weeks to two sets of eight repetitions in weeks 
six to ten and  finally to three sets of eight repetitions in weeks eleven to sixteen. Balance train-
ing was adjusted to individual abilities. The level of difficulty was established by observing the 
participants performing a balance task, e.g. walking on a fitness mat. The participants’ balance 
was progressively challenged by increasing the level of difficulty every two weeks. Functional 
training comprised exercises like chair stands, walking, turning, walking on a course with obsta-
cles. Frequency and duration of both group sessions were one hour twice weekly/two times a 
week during sixteen weeks, 32 in total. The controls followed a non-physical social program 
with information, games and videos in the same weeks. The participants were not allowed to 
participate in other physical activity programs except current physiotherapy. 
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Clinical chemical analyses 
Hemoglobin, estimated glomerular filtration rate (eGFR), HDL-cholesterol, triglycerides and 




All statistical analyses were performed with SPSS version 18.0 for Windows. Results were ex-
pressed as means ± SD or medians [interquartile range (IQR)] for parametric and non-
parametric data, respectively. Available data of non-participants were compared to data of par-
ticipants. Characteristics of exercise and control groups were compared at baseline. Differences 
within groups between end-point minus baseline of each variable were tested by a paired t-test 
or Wilcoxon-signed-ranks-test. Differences across both groups were tested by unpaired tests (t-
test or Mann-Whitney U test). A sub-analysis was made, aimed at those participants who com-
pleted 16 or more (≥50%) of all sessions, who were defined as ‘as treated’. In case of insignifi-
cant differences in the outcomes of the ‘intention-to-treat’ and ‘as treated’ statistical analyses, 
we only report outcomes of the ‘intention-to-treat’ analysis. All statistical comparisons were two-




Subjects’ characteristics  
The number of subjects in four care homes consisted of 434 residents. Of these, 163 (38%) 
were eligible to participate. There were 52/434 (12%) subjects willing to join the study who 
were included (participants), and 111/434 (26%) who refused to take part (non-participants). 
Of the non-participants, 47/111 (42%) were willing to provide us some biometric data only 
once. They also explained their motives not to take part in the study:23/47 repulsed participa-
tion because of intrinsic and 24/47 because of extrinsic motives. Fifty-two participants were 
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assessed at baseline, of which 28/52 were randomized to the exercise group and 24/52 to 
the controls. During the study, 6/434 (1%) participants dropped out because of not exercise-
related reasons: one died after a CVA, two moved to other institutions and three discontinued 
their participation for intrinsic reasons. Their data were excluded from the final analysis. Out of 
52 participants, 46 completed the program, 24/28 of the exercise group and 22/24 of the 
controls.  
No differences were observed between characteristics of the interviewed non-participants 
(n=47) and participants (n=46), except that the non-participants had a more disturbed cogni-
tion compared to the participants (MMSE 30  22 vs. 25; p=0.011). 
The participants were 85 years on average and 65% of them were female (Table 1). T2DM 
occurred in 17% with a mean HbA1c of 43 ± 8 mmol/mol.  Half of them used antihyperten-
sives. Nine (20%) had CHF.  
More females than males and more residents with CHF than without CHF were enrolled in the 
exercise group compared to controls, respectively (79% vs. 50%; p=0.041 and 8 vs. 1; 
p=0.028). In the exercise group, median NT-proBNP (446 vs. 251 pg/mL), systolic blood 
pressure (143 versus 127 mm Hg) and antihypertensive use (83% versus 55%) respectively, 
were significantly higher compared to controls. The exercise group differed from the control 
group neither in fatigue nor in dyspnea. One fall without permanent injury was reported during 
an exercise session  (Table 3). The usual physical activity consisted of one walk a day to an 
indoor restaurant. Residents seldom visited the garden outside. For distances longer than 50-
150 m a wheelchair was used.  
 
Comparison of exercise and control groups before and after intervention 
Within the exercise group, the female waist changed significantly [-8(-15- -2) cm]. The triglyc-
erides changed insignificantly [-6(-19-8)] within the exercise group and significantly [-8(-17-
0)] in the controls. Between-group comparison revealed relevant changes in female waist and 
159 
 
systolic BLOOD PRESSURE, though the findings were not statistically significant. The other 
variables did show neither significant within-group nor between-group differences (Table 4).  
Sub-analysis. In the sub-analysis of participants who attended ≥16 of the sessions (‘as treated’) 
we found a decrease of female waist within the controls [-11(-22-0)cm, p=0.049)], and within 
the exercise group a decrease of triglycerides [-11(-19--1) mg/dL, p=0.032] and an increase 
of NT-proBNP 81(8-155), p=0.33], both insignificant when compared between exercise and 
control group (supplemental Table 4a). There were no other significant or worthwhile between-
group differences detected in this ‘as treated’ sub-analysis. Attendance and endpoints. The 
number of attended sessions was not associated with age, gender and comorbidity.  However, it 




In this study, we questioned whether participation in a predefined exercise program was safe 
and effective to change symptoms, a marker of CHF, and markers of the metabolic syndrome. 
Besides, we regarded participation rates in the interventions. In this pilot study, we found the 
applied exercise program to be safe for residents (1 fall, no lasting injuries). We observed that 
neither metabolic markers nor a marker and symptoms of CHF changed after completing a one 
hour moderate-to-high intensity exercise program, followed twice weekly over a period of 16-
weeks, when compared to controls. It was found that the number of attended sessions in the 
exercise group was inversely related to the change of non-fasting triglycerides from baseline to 
study end. This relation was however not confirmed by a triglycerides decrease after exercise. 
The change in triglycerides suggest that some metabolic change occurred, but this was at most 
genuinely minor. Of the eligible residents, we found one-third (32%) motivated, one-third not 




To explain the results, we assessed population characteristics, exercise frequency, safety, par-
ticipation and attendance. At last, the results of the Benefit study were added  to our outcome. 
Firstly, plasma levels of Hb, HbA1c, triglycerides, HDL-cholesterol, and systolic blood pressure 
were all within reference limits before the intervention. The renal function was only slightly af-
fected. Therefore, it was estimated that participants were properly set up on medications for 
CVD, CHF and metabolic syndrome (e.g. the majority used antihypertensives (Table 3). It was 
noted that doses of antidiabetics, antihypertensives and digitalis remained unchanged during the 
study period. Secondly, we also found that participants had fewer  complaints. Only 27% of the 
exercise and 41% of the control group complained of fatigue and or dyspnea. Thirdly, the high 
age of participants might explain partly why symptom and marker changes did not occur. In 
general, people aged 50 yrs and older, lose muscle strength (mass) and muscle endurance 
(mitochondria), especially when they lead a sedentary life (21). Endurance training, which is 
the best exercise to increase or maintain mitochondrial concentration when aging, has generally 
resulted in relatively small functional benefits for care home residents (22;23). This implies that 
the high-age related changes in muscular and CV physiology, augmented by the CHF disease 
state in some of our participants, limited the exercise capacity and its corresponding benefits. 
Surprisingly, the studied population was stable thanks to  medication. Fourthly, the high intra-
individual variation of NT-proBNP (24) explained the lack of results, which precluded the detec-
tion of minor changes, if any, in a small study group.  
Although the  exercise program used was specifically developed for our study population (16), it 
was questioned whether a (three-times weekly) frequency of three times a week might have 
provided more changes. However, we preferred a twice weekly frequency for fear of more drop-
outs and based on promising results of others (25).  
Measures taken to ensure safety consisted not only of the individual exertion level but also of 
guidance of the training and the own environment where the training sessions were held. Till 
now, effective management of (the) fear of falling is lacking (26). 
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The participation rate of our study consisting of 32% inclusion and 68% refusal, was compared 
with that of another group of 65 years old residents with 49% inclusion and 6% refusal (17). 
This comparison suggested that the higher age of our participants was due to the lower partici-
pation rate. Another reason for the found lower participation rate might be interference of other 
social activities with our interventions. In addition, the reported non-participants were related to 
those with a lower cognition. This suggested that a certain level of cognition may be required to 
participate in a study design as is applied in our study.  
One positive aspect was noted. Most participants remained in the program. Their motivation 
appeared from fewer drop-outs (12%) compared to the number of drop-outs (>20%) found in 
another group of 72 year old exercising residents (17). 
In this study, the attendance (up to 60%) was lower compared to that reported by others (31). 
Accordingly, we analyzed the relations between attendance and all outcome variables in a sub-
group of participants with the best attendance ( ≥50% attendance). Compared to the entire 
group, this subgroup did not exhibit more changes in metabolic markers and symptoms and a 
marker of CHF (supplemental Table 4a). It is therefore unlikely that our results are based on 
lower attendance. Other reasons must account for this. 
Using the same exercise program in comparable cohorts, it is rational to summarize the conclu-
sions of the present study and the Benefit study (20). Both studies conclude that the exercise 
program is ineffective in reducing disability, care-dependency and cardiovascular-metabolic 
endpoints in care home residents. However, on the basis of these two studies, the question 
whether we should advise physical exercise to residents in order to promote health and func-
tionality or not, cannot be answered. As a consequence, we still do not know whether  the 
CVRM recommendations on physical exercise are applicable to care home residents. Subse-
quently, studies in care home residents are warranted. The limitations of the present study were 
the skewed distribution of CHF and gender following randomization and the non-fasting triglyc-






In care-home residents, guided physical exercise is safe in the short term but may be less ef-
fective in reducing chronic heart failure symptoms, NT-proBNP concentrations and the metabolic 
syndrome. We have explained the neutral results by the high age (85 year on average) accom-
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Table 1. Endpoints 
Primary endpoints 
At risk for 
all 
Male Female 
waist circumference (cm)a  >102 >88 
triglycerides (mg/dL)a >150   
high-Density Lipoprotein-cholesterol (mg/dL)a  <40 <50 
systolic blood pressure (mm Hg)a >130   
diastolic blood pressure (mm Hg)a >95   
non-fasting glucose (mg/dL)a <140   
glycated Hemoglobin (mmol/mol) >41   
Secondary endpoints 




dyspnea in 3 activity levels (1 – 3) >1   
N-terminal pro B-type natriuretic peptide( 
pg/mL)b 
>450   
 
a Based on definition of the metabolic syndrome. The severity of fatigue and dyspnea are based 
on the definition of  the NYHA classification: class 1: no symptoms; class 2: symptoms occur at 
ordinary activity; class 3: symptoms occur ordinary activity. b NT-proBNP cut-off  value for the 














Table 2. Sample description. Participants are  compared to non-participants at baseline. 
Variable Participants 




male/female  16/30 9/38 0.151 
age (years) 85 ± 6 84 ± 8 0.658 
body mass index kg/m2 27 ± 5 25 ± 65 0.258 
mini-mental state estimation 30 25 ± 4 22 ± 4 0.011 
heart rate (beats/min) 73 ± 11 71 ± 25 0.522 
smoking median (interquartile range)  3 (1-4)   
heart failure n (%) 9 (%)   
Cerebro-vascular accident  n (%) 16 (%)   
comorbidity 11 (%)   
residents with antidiabetics n (%) 6 (13)   
residents with antihypertensives n(%) 32 (70)   
 
Data are presented as means ± SD. Comorbidity, Charlson Comorbidity Index (sum of current 




Table 3. Characteristics of  exercise and control groups of care home residents. 




       Ex vs. C 
         P-value 
age years mn SD 85±5 84±6 0.298 
male/female number/number  5/19 11/11 0.041 
waistm cm mn SD 107±15 113±28 0.692 
waistf cm mn SD 105±21 97±12 0.690 
mini-mental state examination mn SD 26±3 25±4 0.421 
smoking number 4 7 0.273 
fatigue n  (range 0-3) 1±1 1±1 0.757 
dyspnea n (range 0-3) 1±1 1±1 0.859 
heart rate (beats/min) 71±12 76±9 0.154 
diastolic blood pressure (mm Hg) mn SD 85±12 81±12 0.263 
systolic blood pressure (mm Hg) mn SD 143±9 127±18 0.005 
comorbidity number md IQR 3(0-4) 3(1-4) 0.705 
cerebrovascular accidents  number 7 9 0.353 
diabetes mellitus type 2 number 6 2 0.183 
% residents using antidiabetics  21 1 0.099 
chronic heart failure number 8 1 0.028 
% residents using antihypertensives 83 55 0.037 
digoxin % 8 5 0.671 
NT-proBNP pg/mL median IQR 446 (260-967) 251 (93-664) 0.024 
eGFR mL/min/1.73 m2 mn SD 58±22 70±27 0.098 
hemoglobin mg/dL mn SD 13±2 13±2 0.871 
glucose mg/dL mn SD 118±38 101±20 0.061 
HbA1c mmol/mol  mn SD 43±10 43±6 0.844 
triglycerides mg/dL mn SD 122±56 131±66 0.633 
HDL-cholesterol male  mg/dL mn SD 40±6 51±16 0.139 
HDL-cholesterol female  mg/dL mn SD 51±11 54±22 0.690 
attended sessions% 60±37 58±34 0.840 
fall without injury number 1 0 0.852 




Table 4. Changes (Dif) in the exercise and control groups from baseline to the study end, 





















Dif waist male cm -1 (-4 – 1) 0.135 -3 (-1 – 2) 0.155 -2 (-6 – 2) 0.381 
Dif waist female cm -8 (-15- -2) 0.018 -2 (-6 – 3) 0.405 -4 (-10 – 1) 0.076 
Dif triglycerides mg/dL -6 (-19 – 8) 0.394 -8 (-17- 0) 0.033 -6 (-11- -1) 0.271 
Dif HDL-C male mg/dL 0 (-3 – 3) 0.951 -6 (-18– 6) 0.274 -3 (-11- 5) 0.773 
Dif HDL-C female mg/dL 1 (-3 – 5) 0.577 2 (0 – 5) 0.086 2 (-1- 4) 0.948 
Dif DBP mm Hg -4 (-7 – 0) 0.029 -3 (-10– 4) 0.378 -4 (-8 – 1) 0.935 
Dif SBP mm Hg -1 (-14 – 11) 0.830 2 (-7 – 11) 0.681 -4 (-7- 6) 0.059 
Dif glucose mg/dL -13 (-27–2) 0.078 7 (-5 – 20) 0.228 -7(-26– 13) 0.127 
Dif HbA1c mmol/mol 3 (0 – 6) 0.086 1 (-1 – 3) 0.329 0 (0 – 0) 0.579 
Dif fatigue n 0 (-1 – 0) 0.137 0 (-1 – 0) 0.261 0 (-1- 0) 0.930 
Dif dyspnea n 0 (-1 – 0) 0.328 0 (0 – 0) 0.162 0 (-1- 0) 0.696 
Dif NT-proBNP 
pg/mL*(md IQR) 
334(-117– 785) 0.139 67(7–126) 0.030 22(-9– 140) 0.948 
 
mn, means; SD, standard deviation; * md, median with IQR, interquartile range; MMSE30, 
mini-mental state examination 30; comorbidity, Charlson Comorbidity Index (sum of current 
chronic diseases out of  17 chronic diseases); CVA , cerebrovascular accidents; DBP, diastolic 
blood pressure; SBP, systolic blood pressure; HDL-C, HDL–cholesterol; n, number; NT-
proBNP, amino-terminal proBNP, this variable is tested non-parametrically; eGFR, estimated 




Supplemental Table 4a. Subgroup of attendance ≥16 sessions: changes (Dif) in exercise 
and control groups from baseline to the study end, together with between-group differences 





    Control 
Withingroup 
      Ex vs. C 
  Between-
group 
       adjusted 
 
(Dif) Mn(95%CI) P  Mn(95%CI) P Mn(95%CI) P 
Dif waist m cm -4(-10-3) 0.270 -1(-4-1) 0.135 2(-6-10) 0.601 
Dif waist f cm -2(-7-3) 0.408 -11(-22-0) 0.049 -9(-22-5) 0.190 
Dif triglycerides  -11(-19--1) 0.032 -5(-12-2) 0.134 5(-6-17) 0.563 
Dif HDL-C m -7(-20-7) 0.277 0(-3-3) 1.00 8(-10-25) 0.351 
Dif HDL-C f  25(-29-78) 0.321 2(-1-4) 0.2100 0(-6-6) 0.986 
Dif SBP  2(-10-13) 0.762 0(-14(-14) 0.993 -2(-19-16) 0.540 
Dif HbA1c % 0.1(-0.1-0.2) 0.332 0.1(0.1-1.0) 0.281 0.1(-0.2-0.3) 0.736 
Dif fatigue n 0(0-0) 0.543 0(0-0) 0.136 0(-1-0) 0.543 
Dif dyspnea n 0(0-0) 0.332 0(0-0) 0.229 0(-1-0) 0.670 
Dif NT-proBNP  81(8-155) 0.033 367(-245-981) 0.222 280(-354-914) 0.852 
 
Data are means ±SD; *median with interquartile range (md, iqr); m, male; f, female; DBP, dia-
stolic blood pressure; SBP, systolic blood pressure; HDL-C, HDL–cholesterol; n, number; NT-
proBNP, amino-terminal proBNP this variable is tested non-parametrically. 
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